Clinical Trial Update: Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial update reports testing Envafolimab in combination with neoadjuvant chemotherapy for stage IIb resectable osteosarcoma, with the study currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Envafolimab (envafolimab)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Osteosarcoma, Neoadjuvant Therapy | Phase 2 | Status: NOT_YET_RECRUITING